UBC Medical Indonesia Tbk. vs Singaraja Putra Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Singaraja Putra Tbk. trades at Rp5,975 (market cap 4.01T, 6.85M 24h volume). The key difference: Singaraja Putra Tbk. is far larger — about 7× UBC Medical Indonesia Tbk.'s market cap, and Singaraja Putra Tbk. is more actively traded (6.85M versus 3.48M). Which is the better fit depends on your goals.
| LABS | SINI | |
|---|---|---|
Market Cap | 576.7B | 4.01T |
Volume | 3.48M | 6.85M |
Lot | 34.82K | 68.52K |
Turnover | 522.79M | 41.05B |
Average Price | 150.13 | 5,991.21 |
Value | 522.79M | 41.05B |
Indicative Equilibrium Price | 148 | 5,975 |
Indicative Equilibrium Volume | 350 | 6.31K |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Singaraja Putra Tbk (the Company) was established based on Notarial Deed No. 52 dated November 23, 2005 of Notary Sri Herawati Anwar Effendi, S.H. The Company commenced commercialoperations in 2006.
Read more on SINI →